Skip to main content

and
  1. Article

    Open Access

    A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease

    Bicyclic peptides have great therapeutic potential since they can bridge the gap between small molecules and antibodies by combining a low molecular weight of about 2 kDa with an antibody-like binding specific...

    Tatsuya Ikenoue, Francesco A. Aprile, Pietro Sormanni in Scientific Reports (2020)